Skip to main content

Advertisement

Figure 5 | BMC Research Notes

Figure 5

From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses

Figure 5

Correlation between serum markers for breast cancer. A denotes the correlation between the serum Trx1 and CEA levels in patients with breast cancer (BC); B, the correlation between the serum Trx1 and CA15-3 levels in breast cancerous females; C, the correlation between the serum CEA and CA15-3 levels in patients with breast cancer. Vertical and horizontal solid lines indicate the cut-off values for corresponding marker for breast cancer. The individual values are the average values of three (for Trx1 and CEA) or two (for CA15-3) measurements.

Back to article page